Did you know scar tissue lurks as the unseen adversary within the joint leading to degeneration?
"What if we could prevent scar tissue from
forming after an injury or surgery?"
TX-33 is a unique combination of advanced biomaterials and a pharmaceutical-grade derivative of a molecule used for years by athletes for muscle recovery and repair. This innovative approach, which showed promising results in preventing scar tissue formation in pelvic surgeries during a rigorous double-blind randomized controlled trial, is now being engineered for testing in orthopedic injuries and surgeries.
How does TX-33 intra-articular injection work?
Easily and directly injected into the knee within a specific therapeutic window following injury and/or surgery activates the innate healing mechanisms to restore normal tissue repair vs scar tissue.
Advanced biomaterials engineered to release the molecule locally in a controlled, precise, and targeted way, improving outcomes and minimizing potential systemic side effects
“Growing interest in orthopedics and sports medicine on the use of biology-based treatments, but most lack structure modifying or robust clinical evidence for routine use.”
